Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Gemcitabine is frequently utilized in the treatment of pancreatic ductal adenocarcinoma (PDAC). Its antitumor efficacy is attributed to the processes of intracellular activation and degradation. The active metabolites, gemcitabine diphosphate and triphosphate, play crucial roles by inhibiting ribonucleotide reductase and DNA synthesis, respectively, which ultimately results in the death of cancer cells. The primary enzyme responsible for the inactivation of gemcitabine is cytidine deaminase (CDD)
![Gemcitabine](.data/md-im…